Can Ivermectin lessen risk of COVID-19? Health orgs debunk claims

Both local and international health bodies advised the public against the use of Ivermectin veterinary products to treat COVID-19, citing scant clinical trials on its safety and effectivity.

The Ivermectin is an anti-parasitic drug registered and approved in the Philippines and in the United States for treating parasite infestation such as scabies, lice and other tropical disease.

Since the pandemic started last year, however, there were reports of the medication being sold in some parts of the world, including in the country, as COVID-19 treatment.

In the new advisory posted on March 17, the Department of Health and the country’s Food and Drug Administration stressed that the registered Ivermectin is not approved for viral infections such as COVID-19.

The advisory states, “Ivermectin is NOT APPROVED by the FDA for treatment of any viral infection.”

Both agencies also stressed that the drug is only for certain animal species and not for humans.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.